Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SHORT this PIG all the way to 2.0 - do not fear
Biotech turds like this get pumped and dumped like clockword
hey Surf.can u explain how TSPT special cash dividend works?
Buying into several small cap biotechs like TSPT the past week for move into the new year:
http://stockcharts.com/h-sc/ui?s=tspt&p=D&yr=0&mn=13&dy=0&id=p38090673899
$TSPT recent news/filings
bullish 10-15% in a week or more longer term
## source: finance.yahoo.com
Thu, 03 Jul 2014 18:35:33 GMT ~ TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure
read full: http://biz.yahoo.com/e/140703/tspt8-k.html
*********************************************************
Wed, 02 Jul 2014 05:00:23 GMT ~ Paratek Pharmaceuticals signs merger agreement with NASDAQ-listed Transcept Pharmaceuticals
[at noodls] - NOT FOR DISTRIBUTION IN THE USA, CANADA, JAPAN OR AUSTRALIA Media Release Zug, 2 July 2014 Paratek Pharmaceuticals signs merger agreement with NASDAQ-listed Transcept Pharmaceuticals Paratek Pharmaceuticals, ...
read full: http://www.noodls.com/view/A7D6234787265D35C0D83BC41DB551F05BC16A65
*********************************************************
Tue, 01 Jul 2014 20:12:14 GMT ~ TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
read full: http://biz.yahoo.com/e/140701/tspt8-k.html
*********************************************************
Tue, 01 Jul 2014 10:30:00 GMT ~ Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
[GlobeNewswire] - BOSTON -- Paratek Pharmaceuticals, Inc., today announced that Michael F. Bigham, Partner at Abingworth LLP, has been appointed as Chairman of the Board of Directors and Chief Executive Officer. In addition, ...
read full: http://finance.yahoo.com/news/paratek-appoints-michael-bigham-chairman-103000860.html
*********************************************************
Tue, 01 Jul 2014 10:15:00 GMT ~ Transcept Pharmaceuticals and Paratek Pharmaceuticals Sign Merger Agreement
[PR Newswire] - BOSTON, Mass., and POINT RICHMOND, Calif., July 1, 2014 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (TSPT) and Paratek Pharmaceuticals, Inc., a privately-held biopharmaceutical company, announced today that they have entered into a definitive merger agreement under which the stockholders of Paratek will become the majority owners of Transcept and the operations of Transcept and Paratek will be combined. As part of the proposed transaction, new investors (including The Baupost Group, Abingworth LLP, and other institutional investors); Glenn Oclassen, Chief Executive Officer and Chairman of the Transcept Board, commented: "Following Transcept's recent June 3, 2014 special cash dividend of approximately $25.4 million, this transaction with Paratek reflects the continued commitment of Transcept's Board of Directors and management team to deliver value to Transcept's stockholders. Under the proposed transaction, Transcept's stockholders will maintain a meaningful equity ownership stake in Transcept, which will refocus its operations as a late-stage therapeutics company with product candidates we believe possess significant commercial potential. The transaction also provides for our stockholders an additional special cash dividend and the opportunity to realize any upside potential from our INTERMEZZO and TO-2070 assets."
read full: http://finance.yahoo.com/news/transcept-pharmaceuticals-paratek-pharmaceuticals-sign-101500418.html
*********************************************************
$TSPT charts
basic chart ## source: stockcharts.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$TSPT company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/TSPT/company-info
Ticker: $TSPT
OTC Market Place: Not Available
CIK code: 0001178711
Company name: Transcept Pharmaceuticals, Inc.
Incorporated In:
$TSPT share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$TSPT extra dd links
Company name: Transcept Pharmaceuticals, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/TSPT/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/TSPT/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=TSPT+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=TSPT+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=TSPT+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/TSPT/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/TSPT/news - http://finance.yahoo.com/q/h?s=TSPT+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/TSPT/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/TSPT/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/TSPT/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/TSPT/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/TSPT/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/TSPT/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/TSPT/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/TSPT/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=TSPT+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/TSPT
DTCC (dtcc.com): http://search2.dtcc.com/?q=Transcept+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Transcept+Pharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Transcept+Pharmaceuticals%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/TSPT/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/TSPT
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/TSPT/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/TSPT/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/TSPT/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001178711&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/TSPT/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/TSPT/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/TSPT/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/TSPT/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=TSPT&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=TSPT
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/TSPT/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=TSPT+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=TSPT+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=TSPT
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=TSPT
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=TSPT+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/TSPT/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=TSPT+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/TSPT.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=TSPT
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/TSPT/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/TSPT/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/TSPT/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/TSPT/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/TSPT
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/TSPT
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/TSPT:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=TSPT
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=TSPT
$TSPT DD Notes ~ http://www.ddnotesmaker.com/TSPT
a11k
2:18AM Transcept Pharma provides update on key initiatives to increase shareholder value (TSPT) 3.52 : Co provides an update to the key initiatives being pursued to increase stockholder value.
The Transcept Board and management team have taken, or are undertaking, the following steps:
In November 2013 co announced the reduction of 6 employees, or ~43% of workforce. In connection with this restructuring, Thomas Soloway, Executive Vice President and Chief Operating Officer, notified the Company that he would resign effective December 31, 2013. With these combined changes, co expects that headcount will be reduced by ~50% and our annual payroll and benefits expense will be reduced by ~$1.23 mln, or 37% of the annual Transcept payroll.
Effective December 31, 2013, Glenn Oclassen, President and Chief Executive Officer, will assume the role of Chairman of the Board and Chief Executive Officer. Concurrently, Kirk Raab, the Company's current Chairman of the Board, will move to the position of Lead Independent Director. Christopher Ehrlich, a longstanding member of the Transcept Board of Directors, will resign from the Board effective December 31, 2013. This restructuring is expected save the Company ~$180,000 on an annualized basis, or 36% of its board governance costs.
Co is continuing our work with Leerink Swann, co's previously announced financial and strategic advisor, to explore a range of alternatives to enhance stockholder value, including a sale of the Company, a business combination, partnership opportunities and distribution of all or a significant amount of cash to stockholders. In particular, co is actively seeking a merger partner and intend to continue this effort into the first quarter of 2014, while continuing to remain open to all stockholder value enhancing opportunities. Co is evaluating a range of alternatives, some of which may result in a transaction with a partial distribution of cash to stockholders concurrent with the transaction. If we cannot identify a transaction in the first quarter 2014, co intends to proceed with a liquidation of the Company.
Co will continue to develop TO-2070, our DHE product candidate for the treatment of acute migraine, through the completion of preclinical safety studies. Co believesthat the continued development of TO-2070 through a successful completion of pre-clinical safety studies will add value to the asset that may be recognized in a potential transaction. Given the timing of the strategic process described above, co does not intend to initiate a Phase 1 human pharmacokinetic study.
Co continues to work with Purdue Pharma, our U.S. marketing partner for Intermezzo, to develop and implement strategies to maximize the value of Intermezzo.
7:31AM Transcept Pharma sets special stockholder meeting for Dec 19, 2013; co continues to explore strategic alternatives (TSPT) 3.37 : Co announced that it will hold a special meeting of stockholders on Dec 19, 2013. The meeting arises from a request from a stockholder group that includes: Roumell Asset Management, Retrophin and SC Fundamental Value Fund. This stockholder group is seeking to remove four of the seven current members of the Transcept Board of Directors and to vote on a non-binding resolution calling on the Board to eliminate the Tax Benefit Preservation Plan that the Transcept Board unanimously adopted on Sep 13, 2013 to protect the value of Transcept's cumulative net operating loss carry forwards ("NOLs"). As previously disclosed, the NOLs may have meaningful value to all Transcept stockholders in the future, either to shelter future income or in connection with a strategic transaction.
The co believes that the special meeting request is deficient in a number of respects. However, rather than forcing the stockholder group to revise the request, the Board will call the special meeting to allow all stockholders to make a fully informed decision on these matters. The Transcept Board has established a Nov 5, 2013 record date for stockholders entitled to vote at the special meeting. In contrast to the Board's ongoing exploration of strategic alternatives and other initiatives to create value for all stockholders, the co believes that the objective of this stockholder group is to seize control of Transcept without paying full and fair value to all stockholders.
8:40AM Transcept Pharma announced that it had received a communication from Retrophin stating that it owns 4.9% of the outstanding common stock of TSPT and seeking permission from the Board of Directors of Transcept to increase its ownership stake up to 15% (TSPT) 3.27 : Co announced that it had received a communication from Retrophin stating that it owns 4.9% of the outstanding common stock of Transcept and seeking permission from the Board of Directors of Transcept to increase its ownership stake up to 15% of the outstanding common stock of Transcept. After consultation with its financial and legal advisors, and after evaluating the Retrophin request in the context of the tax benefit preservation plan adopted on September 13, 2013, the Board of Directors of Transcept unanimously determined not to accede to this request.
During its deliberations, the Board of Directors of Transcept determined that granting the Retrophin request could jeopardize the value of the approximately $78 million in net operating loss carry forwards of Transcept. The tax benefit preservation plan was unanimously adopted by the Board to protect this asset for the benefit of all Transcept stockholders.
$TSPT > Technical bounce watch this week >
TSPT has hit the ol' scanner and has a fair chance of a bounce at these levels. Stocks that have declined this badly almost always retrace higher, bounce or dip some and come right back to this point before a further decline.
Contacting me with the fundamentals about the company does not change my criteria for scanning stocks.
If you just started shorting this stock, it might be a bad idea as this is totally oversold!
All of the "FASTLANE's BOMB's AWAY! SCANS" are of my own opinion and not to be used as investment advice.
$TSPT - Investorshub Trades ~ http://ih.advfn.com/p.php?pid=trades&symbol=TSPT
$TSPT - Investorshub Board Search ~ http://investorshub.advfn.com/boards/getboards.aspx?searchstr=TSPT
$TSPT - Investorshub PostStream ~ http://investorshub.advfn.com/boards/poststream.aspx?ticker=TSPT
$TSPT - Investorshub Messages ~ http://investorshub.advfn.com/boards/msgsearch.aspx?SearchStr=TSPT
$TSPT - Investorshub Videos ~ http://ih.advfn.com/p.php?pid=ihvse&ihvqu=TSPT
$TSPT - Investorshub News ~ http://ih.advfn.com/p.php?pid=news&btn=s_ok&ctl00%24sb3%24tbq1=Get+Quote&as_values_IH=&ctl00%24sb3%24stb1=Search+iHub&symbol=TSPT&s_ok=OK&from_month=3&from_day=15&from_year=2012&order=desc&selsrc%5B%5D=prnca&selsrc%5B%5D=prnus&selsrc%5B%5D=zacks&selsrc%5B%5D=money2&selsrc%5B%5D=djn&selsrc%5B%5D=bw&selsrc%5B%5D=globe&selsrc%5B%5D=edgar&selsrc%5B%5D=mwus&force=1&last_ts=1331855999&p_n=1&p_count=&p_ts=1331794260
Regular Candlestick Chart: http://stockcharts.com/h-sc/ui?s=TSPT&p=D&b=3&g=0&id=p04384940601
Regular Candlestick Chart: http://stockcharts.com/h-sc/ui?s=TSPT&p=W&b=3&g=0&id=p04384940601
PennyStockTweets ~ http://www.pennystocktweets.com/stocks/profile/TSPT
OTC Markets Company Info ~ http://www.otcmarkets.com/stock/TSPT/company-info
$TSPT - OTC Markets Charts ~ http://www.otcmarkets.com/stock/TSPT/chart
$TSPT - OTC Markets Quote ~ http://www.otcmarkets.com/stock/TSPT/quote
$TSPT - OTC Markets News ~ http://www.otcmarkets.com/stock/TSPT/news
$TSPT - OTC Markets Financials ~ http://www.otcmarkets.com/stock/TSPT/financials
$TSPT - OTC Markets Short Sales ~ http://www.otcmarkets.com/stock/TSPT/short-sales
$TSPT - OTC Markets Insider Disclosure ~ http://www.otcmarkets.com/stock/TSPT/insider-transactions
$TSPT - OTC Markets Research Reports ~ http://www.otcmarkets.com/stock/TSPT/research
Google Finance Summary ~ http://www.google.com/finance?q=TSPT
$TSPT - $TSPT - Google Finance News ~ http://www.google.com/finance/company_news?q=TSPT
$TSPT - Google Finance Option chain ~ http://www.google.com/finance/option_chain?q=TSPT
$TSPT - Google Finance Financials ~ http://www.google.com/finance?q=TSPT&fstype=ii#
$TSPT - Google Finance Historical prices Daily ~ http://www.google.com/finance/historical?q=TSPT
$TSPT - Google Finance Historical prices Weekly ~ http://www.google.com/finance/historical?q=TSPT&histperiod=weekly#
Y! < Company >
$TSPT - Y! Profile ~ http://finance.yahoo.com/q/pr?s=TSPT+Profile
$TSPT - Y! Key Stat's ~ http://finance.yahoo.com/q/ks?s=TSPT+Key+Statistics
$TSPT - Y! Headlines ~ http://finance.yahoo.com/q/h?s=TSPT+Headlines
$TSPT - Y! Summary ~ http://finance.yahoo.com/q?s=TSPT
$TSPT - Y! Historical Prices ~ http://finance.yahoo.com/q/hp?s=TSPT+Historical+Prices
Y! Order Book ~ http://finance.yahoo.com/q/ecn?s=TSPT+Order+Book
Y! Message Boards ~ http://messages.finance.yahoo.com/mb/TSPT
Y! Market Pulse ~ http://finance.yahoo.com/marketpulse/TSPT
Y! Technical Analysis ~ http://finance.yahoo.com/q/ta?s=TSPT+Basic+Tech.+Analysis
Y! < Analyst Coverage >
Y! Analyst Opinion ~ http://finance.yahoo.com/q/ao?s=TSPT+Analyst+Opinion
Y! Analyst Estimates ~ http://finance.yahoo.com/q/ae?s=TSPT+Analyst+Estimates
Y! Research Reports ~ http://finance.yahoo.com/q/rr?s=TSPT+Research+Reports
Y! Star Analysts ~ http://finance.yahoo.com/q/sa?s=TSPT+Star+Analysts
Y! < Ownership >
Y! Major Holders ~ http://finance.yahoo.com/q/mh?s=TSPT+Major+Holders
Y! Insider Transactions ~ http://finance.yahoo.com/q/it?s=TSPT+Insider+Transactions
Y! Insider Roster ~ http://finance.yahoo.com/q/ir?s=TSPT+Insider+Roster
Y! < Financials >
Y! Income Statement ~ http://finance.yahoo.com/q/is?s=TSPT+Income+Statement&annual
Y! Balance Sheet ~ http://finance.yahoo.com/q/bs?s=TSPT+Balance+Sheet&annual
Y! Cash Flow ~ http://finance.yahoo.com/q/cf?s=TSPT+Cash+Flow&annual
FINVIZ ~ http://finviz.com/quote.ashx?t=TSPT&ty=c&ta=0&p=d
CandlestickChart ~ http://www.candlestickchart.com/cgi/chart.cgi?symbol=TSPT&exchange=US
$TSPT - Barchart Quote ~ http://barchart.com/quotes/stocks/TSPT?
Barchart Detailed Quote ~ http://barchart.com/detailedquote/stocks/TSPT
Barchart Options Quotes ~ http://barchart.com/options/stocks/TSPT
Barchart Technical Chart ~ http://barchart.com/charts/stocks/TSPT&style=technical
Barchart Interactive Chart ~ http://barchart.com/charts/stocks/TSPT&style=interactive
Barchart Technical Analysis ~ http://barchart.com/technicals/stocks/TSPT
Barchart Trader's Cheat Sheet ~ http://barchart.com/cheatsheet.php?sym=TSPT
Barchart Barchart Opinion ~ http://barchart.com/opinions/stocks/TSPT
Barchart Snapshot Opinion ~ http://barchart.com/snapopinion/stocks/TSPT
Barchart News Headlines ~ http://barchart.com/news/stocks/TSPT
Barchart Profile ~ http://barchart.com/profile//TSPT
Barchart Key Statistics ~ http://barchart.com/profile.php?sym=TSPT&view=key_statistics
OTC: American Bulls ~ http://www.americanbulls.com/StockPage.asp?CompanyTicker=TSPT&MarketTicker=OTC&TYP=S
NASDAQ: American Bulls ~ http://www.americanbulls.com/StockPage.asp?CompanyTicker=TSPT&MarketTicker=NASD&TYP=S
NYSE: American Bulls ~ http://www.americanbulls.com/StockPage.asp?CompanyTicker=TSPT&MarketTicker=NYSE&Typ=S
Marketwatch Profile ~ http://www.marketwatch.com/investing/stock/TSPT/profile
Marketwatch Analyst Estimates ~ http://www.marketwatch.com/investing/stock/TSPT/analystestimates
Marketwatch Historical Quotes ~ http://www.marketwatch.com/investing/stock/TSPT/historical
Marketwatch Financials ~ http://www.marketwatch.com/investing/stock/TSPT/financials
Marketwatch Overview ~ http://www.marketwatch.com/investing/stock/TSPT
Marketwatch SEC Filings ~ http://www.marketwatch.com/investing/stock/TSPT/secfilings
Marketwatch Picks ~ http://www.marketwatch.com/investing/stock/TSPT/picks
Marketwatch Hulbert ~ http://www.marketwatch.com/investing/stock/TSPT/hulbert
Marketwatch Insider Actions ~ http://www.marketwatch.com/investing/stock/TSPT/insideractions
Marketwatch Options ~ http://www.marketwatch.com/investing/stock/TSPT/options
Marketwatch Charts ~ http://www.marketwatch.com/investing/stock/TSPT/charts
Marketwatch News ~ http://bigcharts.marketwatch.com/news/symbolsearch/symbolnews.asp?news=markadv&symb=TSPT&sid=1795093&framed=False
The Lion ~ http://thelion.com/bin/aio_msg.cgi?cmd=search&msg=&si=1&tw=1&tt=1&rb=1&ih=1&fo=1&iv=1&yf=1&sa=1&fb=1&gg=1&symbol=TSPT
Search NYSE ~ http://www.nyse.com/about/listed/lcddata.html?ticker=TSPT
StockTA ~ http://www.stockta.com/cgi-bin/analysis.pl?symb=TSPT&num1=567&cobrand=&mode=stock
StockHouse ~ http://www.stockhouse.com/financialtools/sn_overview.aspx?qm_symbol=TSPT
StockHouse Delayed LII ~ http://www.stockhouse.com/financialtools/sn_level2.aspx?qm_page=46140&qm_symbol=TSPT
AlphaTrade ~ http://tools.alphatrade.com/index.php?t1=mc_quote_module&t2=mc_quote_module2&t3=historical&template=historical2html&sym=TSPT&client_id=2740&a_width=680&a_height=1000&language=english&showVol=1&chtype=8
Reuters ~ http://www.reuters.com/finance/stocks/companyOfficers?symbol=TSPT.PK&WTmodLOC=C4-Officers-5
StockWatch ~ http://www.stockwatch.com/Quote/Detail.aspx?symbol=TSPT®ion=U
Search NASDAQ ~ http://www.nasdaq.com/symbol/TSPT
NASDAQ Divy History ~ http://www.nasdaq.com/symbol/TSPT/dividend-history
NASDAQ Short Interest ~ http://www.nasdaq.com/symbol/TSPT/short-interest
NASDAQ Institutional Ownership ~ http://www.nasdaq.com/symbol/TSPT/institutional-holdings
NASDAQ FlashQuotes ~ http://www.nasdaq.com/aspx/flashquotes.aspx?symbol=TSPT&selected=TSPT
NASDAQ InfoQuotes ~ http://www.nasdaq.com/aspx/infoquotes.aspx?symbol=TSPT&selected=TSPT
NASDAQ After Hours Quote ~ http://www.nasdaq.com/symbol/TSPT/after-hours
NASDAQ Pre-Market Quote ~ http://www.nasdaq.com/symbol/TSPT/premarket
NASDAQ Historical Quote ~ http://www.nasdaq.com/symbol/TSPT/historical
NASDAQ Option Chain ~ http://www.nasdaq.com/symbol/TSPT/option-chain
NASDAQ Company Headlines ~ http://www.nasdaq.com/symbol/TSPT/news-headlines
NASDAQ Press Releases ~ http://www.nasdaq.com/symbol/TSPT/news-headlines
NASDAQ Sentiment ~ http://www.nasdaq.com/symbol/TSPT/sentiment
NASDAQ Analyst Summary ~ http://www.nasdaq.com/symbol/TSPT/analyst-research
NASDAQ Guru Analysis~ http://www.nasdaq.com/symbol/TSPT/guru-analysis
NASDAQ Stock Report ~ http://www.nasdaq.com/symbol/TSPT/stock-report
NASDAQ Competitors ~ http://www.nasdaq.com/symbol/TSPT/competitors
NASDAQ Stock Consultant ~ http://www.nasdaq.com/symbol/TSPT/stock-consultant
NASDAQ Stock Comparison ~ http://www.nasdaq.com/symbol/TSPT/stock-comparison
NASDAQ Call Transcripts ~ http://www.nasdaq.com/symbol/TSPT/call-transcripts
NASDAQ Annual Reports ~ http://www.nasdaq.com/aspx/annualreport.aspx?symbol=TSPT&selected=TSPT
NASDAQ Financials ~ http://www.nasdaq.com/symbol/TSPT/financials
NASDAQ Revenue & Earnings Per Share (EPS) ~ http://www.nasdaq.com/symbol/TSPT/revenue-eps
NASDAQ SEC Filings ~ http://www.nasdaq.com/symbol/TSPT/sec-filings
NASDAQ Ownership Summary ~ http://www.nasdaq.com/symbol/TSPT/ownership-summary
NASDAQ Institutional Ownership ~ http://www.nasdaq.com/symbol/TSPT/institutional-holdings
NASDAQ (SEC Form 4) ~
--------- All Trades ~ http://www.nasdaq.com/symbol/TSPT/insider-trades
--------- Buys ~ http://www.nasdaq.com/symbol/TSPT/insider-trades/buys
--------- Sells ~ http://www.nasdaq.com/symbol/TSPT/insider-trades/sells
The Motley Fool ~ http://caps.fool.com/Ticker/TSPT.aspx
The Motley Fool Earnings/Growth ~ http://caps.fool.com/Ticker/TSPT/EarningsGrowthRates.aspx?source=itxsittst0000001
The Motley Fool Ratios ~ http://caps.fool.com/Ticker/TSPT/Ratios.aspx?source=itxsittst0000001
The Motley Fool Stats ~ http://caps.fool.com/Ticker/TSPT/Stats.aspx?source=icasittab0000006
The Motley Fool Historical ~ http://caps.fool.com/Ticker/TSPT/Historical.aspx?source=icasittab0000004
The Motley Fool Scorecard ~ http://caps.fool.com/Ticker/TSPT/Scorecard.aspx?source=icasittab0000003
The Motley Fool Statements ~ http://caps.fool.com/Ticker/TSPT/Statements.aspx?source=icasittab0000009
MSN Money ~ http://investing.money.msn.com/investments/stock-ratings?symbol=TSPT
YCharts ~ http://ycharts.com/companies/TSPT
YCharts Performance ~ http://ycharts.com/companies/TSPT/performance
YCharts Dashboard ~ http://ycharts.com/companies/TSPT/dashboard
InsideStocks Opinion ~ http://www.insidestocks.com/texpert.asp?sym=TSPT&code=XDAILY
InsideStocks Profile ~ http://www.insidestocks.com/profile.asp?sym=TSPT&code=XDAILY
InsideStocks Quote ~ http://www.insidestocks.com/quote.asp?sym=TSPT&code=XDAILY
InsideStocks Projection ~ http://charts3.barchart.com/procal.asp?sym=TSPT
Zacks Quote ~ http://www.zacks.com/stock/quote/TSPT
Zacks Estimates ~ http://www.zacks.com/research/report.php?type=estimates&t=TSPT
Zacks Company Reports ~ http://www.zacks.com/research/report.php?type=report&t=TSPT
Knobias ~ http://knobias.10kwizard.com/files.php?sym=TSPT
StockScores ~ http://www.stockscores.com/quickreport.asp?ticker=TSPT
Trade-Ideas ~ http://www.trade-ideas.com/StockInfo/TSPT/HOT_TOPIC.html
Morningstar ~ http://performance.morningstar.com/stock/performance-return.action?region=USA&t=TSPT&culture=en-US
Morningstar Shareholders ~ http://investors.morningstar.com/ownership/shareholders-overview.html?t=TSPT®ion=USA&culture=en-us
Morningstar Transcripts~ http://www.morningstar.com/earnings/NoTranscript.aspx?t=TSPT®ion=USA
Morningstar Key Ratios ~ http://financials.morningstar.com/ratios/r.html?t=TSPT®ion=USA&culture=en-US
Morningstar Executive Compensation ~ http://insiders.morningstar.com/trading/executive-compensation.action?t=TSPT®ion=USA&culture=en-us
Morningstar Valuation ~ http://financials.morningstar.com/valuation/price-ratio.html?t=TSPT®ion=USA&culture=en-us
CCBN (Thompson Reuters) ~ http://ccbn.aol.com/company.asp?client=aol&ticker=TSPT
TradingMarkets ~ http://pr.tradingmarkets.com/?lid=leftPRbox&sym=TSPT
OTCBB ~ http://www.otcbb.com/asp/SiteSearch.asp?Criteria=TSPT&searcharea=e&image1.x=0&image1.y=0
Insidercow ~ http://www.insidercow.com/history/company.jsp?company=TSPT&B1=Search%21
Forbes News ~ http://search.forbes.com/search/find?tab=searchtabgeneraldark&MT=TSPT
Forbes Press Releases ~ http://search.forbes.com/search/find?&start=1&tab=searchtabgeneraldark&MT=TSPT&pub=businesswire,prnewswire&searchResults=pressRelease&tag=pr&premium=on
Forbes Web ~ http://search.forbes.com/search/web?MT=TSPT&start=1&max=10&searchResults=web&tag=web&sort=null
YouTube Symbol Search ~ http://www.youtube.com/results?search_query=TSPT
Buy-Ins ~ http://www.buyins.net/tools/symbol_stats.php?sym=TSPT
Quotemedia ~ http://www.quotemedia.com/results.php?qm_page=47556&qm_symbol=TSPT
Earnings Whispers ~ http://www.earningswhispers.com/stocks.asp?symbol=TSPT
Bloomberg Snapshot ~ http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=TSPT
Bloomberg People ~ http://investing.businessweek.com/research/stocks/people/people.asp?ticker=TSPT
Financial Times ~ http://markets.ft.com/Research/Markets/Tearsheets/Summary?s=TSPT
Investorpoint ~ http://www.investorpoint.com/ enter "TSPT" and click search.
Hotstocked ~ http://www.hotstocked.com/ enter "TSPT" and click search.
Raging Bull ~ http://ragingbull.quote.com/mboard/boards.cgi?board=TSPT
Hoovers ~ http://www.hoovers.com/search/company-search-results/100003765-1.html?type=company&term=TSPT
DD Machine ~ http://www.ddmachine.com/default.asp?m=stocktool_frame.asp?symbol=TSPT
SEC Form 4 ~ http://www.secform4.com/insider/showhistory.php?cik=TSPT
OTCBB Pulse ~ http://www.otcbbpulse.com/cgi-bin/pulsequote.cgi?symbol=TSPT
Failures To Deliver ~ http://failurestodeliver.com/default2.aspx enter "TSPT" and click search.
http://www.coordinatedlegal.com/SecretaryOfState.html
http://regsho.finra.org/regsho-Index.html
http://www.shortsqueeze.com/?symbol=TSPT&submit=Short+Quote%99
Showing some small volume growth here...any thoughts ??
1:38AM Transcept Pharma comments on new FDA Dosage reduction requirements for Zolpidem based prescription sleep aids administered at bedtime (TSPT) 5.76 : The FDA is requiring that the manufacturers of certain zolpidem based prescription sleep aids such as Ambien and Ambien CR, and generic versions of these products, reduce the recommended dose. FDA has informed the manufacturers of these products that the recommended dose of zolpidem at bedtime for women should be lowered from 10 mg to 5 mg for immediate-release products such as Ambien, and from 12.5 mg to 6.25 mg for extended-release products such as Ambien CR. FDA also informed the manufacturers that, for men, the labeling should recommend that health care professionals consider prescribing the lower doses 5 mg for immediate-release products and 6.25 mg for extended-release products.
The FDA announcement further states, "The recommended doses of Intermezzo, a lower dose zolpidem product approved for middle-of-the-night awakenings, are not changing. At the time of Intermezzo's approval in November 2011, the label already recommended a lower dosage for women than for men." Co states: "We are pleased that this action by FDA confirms the recommended dose of Intermezzo at 3.5 mg in men and 1.75 mg in women for the treatment of insomnia when a middle of the night awakening is followed by difficulty returning to sleep, so long as they have at least 4 hours of remaining bedtime."